Skip to main content

Table 1 Descriptive characteristics of the study population, overall and stratified by current statin use

From: Effects of statin use on volumetric mammographic density: results from the KARMA study

Participant characteristica

Total

Statin use

P value

  

No

Yes

 

N = 37,765

N = 3,337

Age (years), mean (SD)

55.0 (9.8)

54.2 (9.6)

63.8 (6.9)

<0.001

Body mass index (kg/m2), mean (SD)

25.4 (4.2)

25.2 (4.2)

27.1 (4.6)

<0.001

Age at menarche (years), mean (SD)

13.1 (1.5)

13.1 (1.5)

13.3 (1.5)

<0.001

Parity, % (N)

   

0.54

0

12.1 (4,979)

12.2 (4,582)

11.9 (397)

1

14.1 (5,792)

14.0 (5,294)

15.0 (498)

2

48.5 (19,901)

48.5 (18,296)

48.2 (1,605)

> = 3

25.3 (10,363)

25.3 (9,533)

24.9 (830)

Age at first birth (years), mean (SD)

27.1 (5.2)

27.2 (5.2)

25.0 (4.6)

<0.001

Menopausal status, % (N)

   

<0.001

Premenopausal

40.2 (16,506)

43.1 (16,272)

7.0 (234)

Perimenopausal/unknown

3.3 (1,349)

3.5 (1,304)

1.4 (45)

Postmenopausal

56.6 (23,247)

53.5 (20,189)

91.6 (3,058)

Oral contraceptive use, % (N)

79.7 (32,602)

80.5 (30,257)

70.9 (2,345)

<0.001

Hormone replacement therapy, % (N)

   

<0.001

Never

80.5 (30,791)

81.7 (28,809)

65.6 (1,982)

Former

15.5 (5,945)

14.3 (5,040)

30.0 (905)

Current

4.0 (1,521)

4.0 (1,395)

4.2 (126)

Benign breast disease, % (N)

22.1 (8,919)

22.0 (8,156)

23.3 (763)

0.09

Family history of breast cancer, % (N)

13.2 (5,236)

13.2 (4,815)

13.2 (421)

0.91

Low-dose aspirin use, % (N)

4.7 (1,911)

2.2 (833)

32.3 (1,078)

<0.001

Metformin use, % (N)

1.6 (666)

0.7 (263)

12.1 (403)

<0.001

Education, % (N)

   

<0.001

Compulsory

14.4 (5,705)

12.9 (4,726)

31.2 (979)

Gymnasium

31.6 (12,557)

31.9 (11,664)

28.5 (893)

University

54.0 (21,440)

55.2 (20,178)

40.3 (1,262)

Smoking status, % (N)

   

<0.001

Never

48.2 (19,750)

48.8 (18,400)

40.6 (1,350)

Former

39.7 (16,269)

39.1 (14,726)

46.4 (1,543)

Current

12.2 (4,984)

12.1 (4,551)

13.0 (433)

Alcohol (g/week), % (N)

   

<0.001

0

19.4 (7,912)

18.9 (7,090)

24.9 (822)

1–25

24.0 (9,788)

24.3 (9,110)

20.5 (678)

25–50

28.1 (11,471)

28.4 (10,640)

25.2 (831)

50–100

14.6 (5,949)

14.6 (5,481)

14.2 (468)

>100

13.9 (5,666)

13.8 (5,162)

15.3 (504)

  1. aMissingness on all variables < 5 %, except for age at first birth (5.6 %) and hormone replacement therapy (6.9 %)